Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$36.85 USD
+2.22 (6.41%)
Updated May 3, 2024 04:00 PM ET
After-Market: $36.75 -0.10 (-0.27%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $-1.15 | 11.18% |
Earnings Summary
For their last quarter, Tarsus Pharmaceuticals (TARS) reported earnings of -$1.31 per share, beating the Zacks Consensus Estimate of $-1.37 per share. This reflects a positive earnings surprise of 4.38%. Look out for TARS's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of -$1.15 per share, reflecting a year-over-year decrease of 30.68%.
Earnings History
Price & Consensus
Zacks News for TARS
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
TARS: What are Zacks experts saying now?
Zacks Private Portfolio Services